Urine Analysis

PreclinicalBiologic

OOhio State University

Urine Analysis is one of 45 biologic programs targeting Obese. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ObeseCompleted

TreatmentTerminated

ObesePreclinical

Completed

TreatmentPreclinical

Terminated

Competition

Competitive Landscape

350 competitors in Treatment

#DrugCompanyPhaseTrials

Alfenta

Jazz Pharmaceuticals

Preclinical

1 2

Niclocide

Bayer

Preclinical

1 3

Minipress

Pfizer

Preclinical

1 4

Theo-Dur

Pfizer

Preclinical

1 5

Levulan

Sun Pharmaceutical Industries, Inc.

Preclinical

1 6

Lamprene

Novartis

Preclinical

1 7

Emtriva

Gilead

Preclinical

1 8

Hivid

CConrado Roberto Hoffmann Filho

Preclinical

6 9

Foscavir

CClinigen, Inc.

Preclinical

6 10

Clomid

Ferring

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Obese1 trial

Impact of Exogenous Ketones on Indices of Keto-Adaptation in Obese Subjects on Weight Reducing Diets.

Completed·OOhio State University·N/A·NCT06449287·37 enrolled

Treatment1 trial

Pharmacogenetic and Antidepressant Treatment in Elderly

Terminated·—·N/A·NCT02856477·28 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Urine Analysis. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Urine Analysis compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Urine Analysis. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ohio State University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: OOhio State University

Urine Analysis

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Obese1 trial

Treatment1 trial

References

Drug Info

Quick Facts

Related News